VisionCare: VisionCare Names Thomas Ruggia as CEO

SARATOGA, Calif.-VisionCare, a developer of advanced visual prosthetic devices for the treatment of age-related macular degeneration (AMD), announced that Thomas Ruggia has been appointed as the company's new chief executive officer, effective July 6, 2020. Wolfgang Tolle, who most recently served as CEO and executive chairman of the board, has left VisionCare to focus on new opportunities. Before joining VisionCare, Ruggia spent five years at Johnson & Johnson, working at Johnson & Johnson Vision and The Janssen Pharma Co, respectively.